Efficacy of intra‐arterial thrombolytic therapy for vision loss resulting from hyaluronic acid filler embolization

Abstract

Our results indicate that IATT is feasible for patients with vision loss induced by HA embolism. IATT combined with conventional sequential therapy was beneficial in the recovery from other serious HA embolism complications. Nevertheless, the underlying pathophysiological mechanism needs to be clarified in future animal experiments.